Antiplatelet Drug Ticagrelor Enhances Chemotherapeutic Efficacy by Targeting the Novel P2Y12-AKT Pathway in Pancreatic Cancer Cells
出版年份 2020 全文链接
标题
Antiplatelet Drug Ticagrelor Enhances Chemotherapeutic Efficacy by Targeting the Novel P2Y12-AKT Pathway in Pancreatic Cancer Cells
作者
关键词
-
出版物
Cancers
Volume 12, Issue 1, Pages 250
出版商
MDPI AG
发表日期
2020-01-21
DOI
10.3390/cancers12010250
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- P2Y12 Receptors in Tumorigenesis and Metastasis
- (2018) Patrizia Ballerini et al. Frontiers in Pharmacology
- Understanding the biology of HER3 receptor as a therapeutic target in human cancer
- (2018) Hui Lyu et al. Acta Pharmaceutica Sinica B
- Identification of Novel Cdc7 Kinase Inhibitors as Anti-Cancer Agents that Target the Interaction with Dbf4 by the Fragment Complementation and Drug Repositioning Approach
- (2018) An Ning Cheng et al. EBioMedicine
- Cancer-Associated Thrombosis: An Overview of Mechanisms, Risk Factors, and Treatment
- (2018) Norbaini Abdol Razak et al. Cancers
- Ticagrelor, but not clopidogrel active metabolite, displays antithrombotic properties in the left atrial endocardium
- (2017) Martin F. Reiner et al. EUROPEAN HEART JOURNAL
- Protease-activated receptor-4 and purinergic receptor P2Y12 dimerize, co-internalize, and activate Akt signaling via endosomal recruitment of β-arrestin
- (2017) Thomas H. Smith et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer
- (2017) Angela M. Krebs et al. NATURE CELL BIOLOGY
- GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
- (2017) Zefang Tang et al. NUCLEIC ACIDS RESEARCH
- Targeting Platelets for the Treatment of Cancer
- (2017) Omar Elaskalani et al. Cancers
- The Role of Platelet-Derived ADP and ATP in Promoting Pancreatic Cancer Cell Survival and Gemcitabine Resistance
- (2017) Omar Elaskalani et al. Cancers
- Inverse agonism at the P2Y12 receptor and ENT1 transporter blockade contribute to platelet inhibition by ticagrelor
- (2016) R. Aungraheeta et al. BLOOD
- Nucleotides and nucleoside signaling in the regulation of the epithelium to mesenchymal transition (EMT)
- (2016) A. S. Martínez-Ramírez et al. Purinergic Signalling
- Long-term survival in patients with pancreatic ductal adenocarcinoma
- (2016) Alexander P. Stark et al. SURGERY
- Current State and Novel Approaches of Antiplatelet Therapy
- (2015) P. Metharom et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Efficacy of Prophylactic Low–Molecular Weight Heparin for Ambulatory Patients With Advanced Pancreatic Cancer: Outcomes From the CONKO-004 Trial
- (2015) Uwe Pelzer et al. JOURNAL OF CLINICAL ONCOLOGY
- P2Y12 Receptor Localizes in the Renal Collecting Duct and Its Blockade Augments Arginine Vasopressin Action and Alleviates Nephrogenic Diabetes Insipidus
- (2015) Y. Zhang et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- BAG3 promotes pancreatic ductal adenocarcinoma growth by activating stromal macrophages
- (2015) Alessandra Rosati et al. Nature Communications
- P2Y2 receptor promotes cell invasion and metastasis in prostate cancer cells
- (2013) W-H Li et al. BRITISH JOURNAL OF CANCER
- A pharmacokinetic interaction study of ticagrelor and digoxin in healthy volunteers
- (2013) Renli Teng et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- ATP-Mediated Transactivation of the Epidermal Growth Factor Receptor in Airway Epithelial Cells Involves DUOX1-Dependent Oxidation of Src and ADAM17
- (2013) Derek Sham et al. PLoS One
- P2Y12protects platelets from apoptosis via PI3k-dependent Bak/Bax inactivation
- (2012) S. ZHANG et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Evaluation of the pharmacokinetics and pharmacodynamics of ticagrelor co-administered with aspirin in healthy volunteers
- (2012) Renli Teng et al. PLATELETS
- nab -Paclitaxel Potentiates Gemcitabine Activity by Reducing Cytidine Deaminase Levels in a Mouse Model of Pancreatic Cancer
- (2012) Kristopher K. Frese et al. Cancer Discovery
- Direct Signaling between Platelets and Cancer Cells Induces an Epithelial-Mesenchymal-Like Transition and Promotes Metastasis
- (2011) Myriam Labelle et al. CANCER CELL
- P2Y12 receptor in platelet activation
- (2011) Soochong Kim et al. PLATELETS
- Ticagrelor Effectively and Reversibly Blocks Murine Platelet P2Y 12 -Mediated Thrombosis and Demonstrates a Requirement for Sustained P2Y 12 Inhibition to Prevent Subsequent Neointima
- (2010) Shankar B. Patil et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- P2Y2Nucleotide Receptors Mediate Metalloprotease-dependent Phosphorylation of Epidermal Growth Factor Receptor and ErbB3 in Human Salivary Gland Cells
- (2010) Ann M. Ratchford et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Adenosine A1 receptor-mediated transactivation of the EGF receptor produces a neuroprotective effect on cortical neurons in vitro
- (2009) Ke-qiang Xie et al. ACTA PHARMACOLOGICA SINICA
- Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study
- (2009) Giancarlo Agnelli et al. LANCET ONCOLOGY
- Studies on the role of the extracellular cysteines and oligomeric structures of the P2Y12receptor when interacting with antagonists
- (2008) ZHONGREN DING et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- LY2109761, a novel transforming growth factor receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis
- (2008) D. Melisi et al. MOLECULAR CANCER THERAPEUTICS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started